Can peripheral psychophysiological markers predict response to exposure-based cognitive behavioral therapy in youth with severely impairing irritability? A study protocol

• Published in: BMC psychiatry Vol. 23; no. 1; pp. 926 - 11
• Main Authors: Grasser, Lana Ruvolo, Erjo, Trinity, Goodwin, Matthew S, Naim, Reut, German, Ramaris E, White, Jamell, Cullins, Lisa, Tseng, Wan-Ling, Stoddard, Joel, Brotman, Melissa A
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 11-12-2023; BioMed Central; BMC
• Subjects: Adolescent; Affect (Psychology); Analysis; Anger; Anxiety disorders; Arousal; Attention deficit hyperactivity disorder; Behavior modification; Biosensors; Cognitive ability; Cognitive behavioral therapy; Cognitive Behavioral Therapy - methods; Cognitive therapy; Electrodermal activity; Emotional regulation; Emotions; Exposure; Female; Health aspects; Heart rate; Heart rate variability; Humans; Irritability; Irritable Mood; Male; Nervous system; Neurobiology; Patient outcomes; Physiological psychology; Physiology; Post traumatic stress disorder; Psychiatric services; Psychological aspects; Psychopathology; Psychophysiology; Research Design; Social aspects; Study Protocol; Teenagers; Treatment Outcome; Youth; United States; Heart rate; Intervention; Electrodermal activity; Cognitive behavioral therapy; Irritability; Children and adolescents; Exposure; Heart rate variability
• ISSN: 1471-244X; 1471-244X
• DOI: 10.1186/s12888-023-05421-4

Irritability, an increased proneness to anger, is a primary reason youth present for psychiatric care. While initial evidence supports the efficacy of exposure-based cognitive behavioral therapy (CBT) for youth with clinically impairing irritability, treatment mechanisms remain unclear. Here, we propose to measure peripheral psychophysiological indicators of arousal-heart rate (HR)/electrodermal activity (EDA)-and regulation-heart rate variability (HRV)-during exposures to anger-inducing stimuli as potential predictors of treatment efficacy. The objective of this study is to evaluate whether in-situ biosensing data provides peripheral physiological indicators of in-session response to exposures.
Blood volume pulse (BVP; from which HR and HRV canl be derived) and EDA will be collected ambulatorily using the Empatica EmbracePlus from 40 youth (all genders; ages 8-17) undergoing six in-person exposure treatment sessions, as part of a multiple-baseline trial of exposure-based CBT for clinically impairing irritability. Clinical ratings of irritability will be conducted at baseline, weekly throughout treatment, and at 3-month and 6-month follow-ups via the Clinical Global Impressions Scale (CGI) and the Affective Reactivity Index (ARI; clinician-, parent-, and child-report). Multilevel modeling will be used to assess within- and between-person changes in physiological arousal and regulation throughout exposure-based CBT and to determine whether individual differences are predictive of treatment response.
This study protocol leverages a wearable biosensor (Empatica) to continuously record HR/HRV (derived from BVP) and EDA during in-person exposure sessions for youth with clinically impairing irritability. Here, the goal is to identify changes in physiological arousal (EDA, HR) and regulation (HRV) over the course of treatment in tandem with changes in clinical symptoms.
The participants in this study come from an overarching clinical trial (trial registration numbers: NCT02531893 first registered on 8/25/2015; last updated on 8/25/2023). The research project and all related materials were submitted and approved by the appropriate Institutional Review Board of the National Institute of Mental Health (NIMH).